Alcohol Consumption: Clinical Trials

3 trials for Alcohol Consumption, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Withdrawn 1

Follow Alcohol Consumption: new trials by email Literature Review of Alcohol Consumption trials Research Report on Alcohol Consumption

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Varenicline in Heavy Drinking Smokers
Varenicline, Placebo pill (for varenicline), Alcohol - Cigarette Smoking, Alcohol Consumption
Phase 4WithdrawnUniversity of California, Los Angeles2015-08-012018-06-01
Naltrexone for Heavy Drinking in Young Adults
BASICS counseling, naltrexone, placebo naltrexone - Alcohol Consumption, Alcoholic Intoxication
Phase 4CompletedYale University1402008-02-012020-03-30
Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders
Vivitrol (Medication Therapy), Medication Management Therapy - Alcohol Consumption
Phase 4CompletedPacific Institute for Research and Evaluation142007-04-012012-08-27

Narrower conditions

Alcohol Drinking (3)  ·  Alcohol-Induced Disorders (1)  ·  Alcoholic Intoxication (1)  ·  Alcoholism (1)  ·  Cigarette Smoking (1)

Broader conditions

Behavior (3)  ·  Drinking Behavior (3)  ·  Alcohol-Related Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Smoking (1)  ·  Substance-Related Disorders (1)  ·  Tobacco Smoking (1)  ·  Tobacco Use (1)

Interventions

Crisis Intervention (1)  ·  Drug Therapy (1)  ·  Ethanol (1)  ·  Medication Therapy Management (1)  ·  Naltrexone (1)  ·  Varenicline (1)  ·  WW Domain-Containing Oxidoreductase (1)  ·  vivitrol (1)

Sponsors

Pacific Institute for Research and Evaluation (1)  ·  University of California, Los Angeles (1)  ·  Yale University (1)

Countries

United States (3)

Top investigators

Sandra Lapham, MD, MPH (1)  ·  Stephanie O'Malley, PhD (1)

Results publications

PMID 25742208

NIH funding

R01AA016621 (1)